Avantor, Inc. (AVTR)
Stock Price Chart
Key Info
| Market Cap | 14.68B |
| Revenue (ttm) | 6.03B |
| Net Income (ttm) | 199.90M |
| Shares Out | 576.63M |
| EPS (ttm) | 0.23 |
| PE Ratio | 110.65 |
| Forward PE | 23.09 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 22, 2020 |
| Last Price | $25.45 |
| Previous Close | $24.71 |
| Change ($) | 0.74 |
| Change (%) | 2.99% |
| Day's Open | 24.85 |
| Day's Range | 24.70 - 25.56 |
| Day's Volume | 5,767,666 |
| 52-Week Range | 6.66 - 25.70 |
More Stats
| Market Cap | 14.68B |
| Enterprise Value | 19.34B |
| Earnings Date (est) | Oct 28, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 576.63M |
| Float | 520.16M |
| EPS (basic) | 0.43 |
| EPS (diluted) | 0.23 |
| FCF / Share | 1.00 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 0.90% |
| FCF Yield | 3.92% |
| Payout Ratio | n/a |
| Shares Short | 13.61M |
| Short Ratio | 2.51 |
| Short % of Float | 2.62% |
| Beta | n/a |
| PE Ratio | 110.65 |
| Forward PE | 23.09 |
| P/FCF Ratio | 25.48 |
| PS Ratio | 2.44 |
| PB Ratio | 9.18 |
| Revenue | 6.03B |
| Operating Income | 620.10M |
| Net Income | 199.90M |
| Free Cash Flow | 575.90M |
| Net Cash | -4.66B |
| Net Cash / Share | -8.09 |
| Gross Margin | 31.88% |
| Operating Margin | 10.29% |
| Profit Margin | 2.20% |
| FCF Margin | 9.56% |
| ROA | 4.10% |
| ROE | 8.07% |
| ROIC | 9.30% |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|
| Revenue | 6,040 | 5,864 | 1,247 | 691 |
| Revenue Growth | 3% | 370.12% | 80.44% | - |
| Gross Profit | 1,921 | 1,820 | 433 | 320 |
| Operating Income | 552 | 414 | -210 | 9.90 |
| Net Income | 37.80 | -86.90 | -113 | -42.40 |
| Shares Outstanding | 401 | 133 | 151 | 153 |
| Earnings Per Share | -0.84 | -2.69 | -2.75 | -0.28 |
| Operating Cash Flow | 354 | 201 | -168 | 72.90 |
| Capital Expenditures | -51.60 | -37.70 | -25.20 | -29.90 |
| Free Cash Flow | 302 | 163 | -193 | 43.00 |
| Cash & Equivalents | 187 | 185 | 185 | - |
| Total Debt | 5,117 | 6,925 | 7,118 | - |
| Net Cash / Debt | -4,930 | -6,740 | -6,932 | - |
| Assets | 9,773 | 9,912 | 10,447 | - |
| Liabilities | 7,311 | 9,104 | 9,477 | - |
| Book Value | 2,462 | -3,052 | -2,620 | - |
Company Profile
Company Details
| Full Name | Avantor, Inc. |
| Country | United States |
| Employees | 12,000 |
| CEO | Michael Stubblefield |
Stock Information
| Ticker Symbol | AVTR |
| Stock Exchange | New York Stock Exchange |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Unique Identifier | NYSE: AVTR |
| IPO Date | May 17, 2019 |
Description
Avantor provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.